Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"BMC cancer"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Shi%2C+Yuankai%22&type=Person&filter%5B%5D=journalStr%3A%22BMC+cancer%22
/vufind/Search/Results?lookfor=%22Shi%2C+Yuankai%22&type=Person&filter%5B%5D=journalStr%3A%22BMC+cancer%22
Search /vufind/Search2/Results?lookfor=%22Shi%2C+Yuankai%22&type=Person&filter%5B%5D=journalStr%3A%22BMC+cancer%22
PubPharm (10)
1
Long-term outcomes with HLX01 (HanliKang®), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma : 5-year follow-up results of the phase 3 HLX01-NHL03 study
enthalten in:
BMC cancer
| 2024
von
Qin, Y.
|
Song, Y.
|
Wang, D.
| +25
Wird geladen...
2
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer : a phase Ib study
enthalten in:
BMC cancer
| 2023
von
Hu, X.
|
Cui, X.
|
Wang, Z.
| +16
Wird geladen...
3
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study
enthalten in:
BMC cancer
| 2023
von
Hu, X.
|
Cui, X.
|
Wang, Z.
| +16
Wird geladen...
4
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study
enthalten in:
BMC cancer
| 2023
von
Hu, X.
|
Cui, X.
|
Wang, Z.
| +16
Wird geladen...
5
Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer
enthalten in:
BMC cancer
| 2023
von
Huang, L.
|
Feng, Y.
|
Xie, T.
| +3
Wird geladen...
6
Safety, pharmacokinetics and efficacy of SCT200, an anti-EGFR monoclonal antibody in patients with wild-type KRAS/NRAS/BRAF metastatic colorectal cancer : a phase I dose-escalation and dose-expansion study
enthalten in:
BMC cancer
| 2022
von
Zhang, W.
|
Han, X.
|
Yang, L.
| +5
Wird geladen...
7
Safety, pharmacokinetics and efficacy of SCT200, an anti-EGFR monoclonal antibody in patients with wild-type KRAS/NRAS/BRAF metastatic colorectal cancer: a phase I dose-escalation and dose-expansion study
enthalten in:
BMC cancer
| 2022
von
Zhang, W.
|
Han, X.
|
Yang, L.
| +5
Wird geladen...
8
Safety, pharmacokinetics and efficacy of SCT200, an anti-EGFR monoclonal antibody in patients with wild-type KRAS/NRAS/BRAF metastatic colorectal cancer: a phase I dose-escalation and dose-expansion study
enthalten in:
BMC cancer
| 2022
von
Zhang, W.
|
Han, X.
|
Yang, L.
| +5
Wird geladen...
9
Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width : a new prognostic model for diffuse large B-cell lymphoma in the rituximab era
enthalten in:
BMC cancer
| 2022
von
Chen, H.
|
Zhong, Q.
|
Zhou, Y.
| +10
Wird geladen...
10
Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era
enthalten in:
BMC cancer
| 2022
von
Chen, H.
|
Zhong, Q.
|
Zhou, Y.
| +10
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: BMC cancer
Medienart
10
Aufsätze
10
E-Artikel
10
E-Ressourcen
Zeitschriftentitel
BMC cancer
Thema
5
Journal Article
3
BPI-9016M
3
Colorectal cancer
3
Efficacy
3
Epidermal Growth Factor Receptor
3
Mesenchymal-epithelial transition factor
3
Monoclonal antibodies
3
Non-small-cell lung cancer
3
Pharmacokinetics
3
SCT200
3
Safety
2
4F4X42SYQ6
2
Clinical Trial, Phase I
2
Diffuse large B-cell lymphoma
2
International prognostic index
2
Platelet count
2
Prognosis
2
Randomized Controlled Trial
2
Red blood cell distribution width
2
Rituximab
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2024
4
2023
5
2022
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10
Englisch
Haven't found what you're looking for?
Wird geladen...